We are live on ! Find out more
HAE icon

Haemonetics
HAE

242 hedge funds and large institutions have $3.26B invested in Haemonetics in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 83 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

97% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.81M

23% more capital invested

Capital invested by funds: $2.65B → $3.26B (+$604M)

17% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 83

2.9% more ownership

Funds ownership: 97.99% → 100.9% (+2.9%)

6% less funds holding

Funds holding: 257 → 242 (-15)

33% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 42

Holders
242
Holders Change
-15
Holders Change %
-5.84%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
97
Reduced
83
Closed
42
Calls
$3.56M
Puts
$1.81M
Net Calls
+$1.75M
Net Calls Change
-$10.3M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$185M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.4M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$17.4M
4
EA
Emerald Advisers
Pennsylvania
+$14.5M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$12.1M

Top Sellers

1
AC
Armistice Capital
New York
-$46.3M
2
BlackRock
BlackRock
New York
-$40.3M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$40M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$23.6M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$390M +$59.4M +1,091,484 +22%
BlackRock
2
BlackRock
New York
$376M -$40.3M -740,621 -11%
Capital Research Global Investors
3
Capital Research Global Investors
California
$345M +$185M +3,402,873 +166%
Vanguard Group
4
Vanguard Group
Pennsylvania
$310M +$1.57M +28,960 +0.6%
Neuberger Berman Group
5
Neuberger Berman Group
New York
$238M -$5.84M -107,435 -3%
State Street
6
State Street
Massachusetts
$110M +$2.36M +43,396 +3%
Franklin Resources
7
Franklin Resources
California
$93M +$200K +3,677 +0.3%
Fisher Asset Management
8
Fisher Asset Management
Washington
$75.1M -$353K -6,487 -0.5%
LCOV
9
London Company of Virginia
Virginia
$61.4M +$2.92M +53,653 +6%
LCP
10
LGT Capital Partners
Switzerland
$61.1M -$13.6M -249,560 -21%
RRAM
11
River Road Asset Management
Kentucky
$59.6M +$7.97M +146,641 +18%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$55.7M +$1.81M +33,205 +4%
BTW
13
Boston Trust Walden
Massachusetts
$52.5M +$10.3M +189,457 +30%
RA
14
Royce & Associates
New York
$47.9M +$2.67M +49,136 +7%
Northern Trust
15
Northern Trust
Illinois
$42.9M -$1.56M -28,674 -4%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$39.4M +$3.76M +69,141 +12%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$38.7M +$1.43M +26,233 +4%
Westfield Capital Management
18
Westfield Capital Management
Massachusetts
$34.9M -$40M -735,366 -57%
Charles Schwab
19
Charles Schwab
California
$31.6M +$1.91M +35,078 +8%
Schroder Investment Management Group
20
Schroder Investment Management Group
United Kingdom
$30.9M -$3.07M -56,484 -10%
Federated Hermes
21
Federated Hermes
Pennsylvania
$29.2M +$17.4M +320,184 +225%
Two Sigma Investments
22
Two Sigma Investments
New York
$28.5M +$1.4M +25,784 +6%
Morgan Stanley
23
Morgan Stanley
New York
$27.9M +$169K +3,115 +0.7%
HA
24
Heartland Advisors
Wisconsin
$27.8M +$1.82M +33,554 +8%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$26.3M +$6.26M +115,100 +38%
1
2 3 4 5

HAE Hedge Fund Activity: Q1 2022 in Review

242 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2022, worth a combined $3.26B — up 23% from $2.65B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of HAE and 28 opened new positions — a net loss of 14 holders — while 83 trimmed existing stakes and 97 added.

The largest buyer was Capital Research Global Investors, adding an estimated $185M. The largest seller was Armistice Capital, exiting entirely with an estimated $46.3M sold.

  • 242 institutional investors held Haemonetics (HAE) as of Q1 2022, down from 257 in Q4 2021.
  • Funds reported $3.26B of Haemonetics stock for Q1 2022, up 23% quarter-over-quarter.
  • 28 funds opened new Haemonetics positions in Q1 2022 and 42 closed out, a net change of -14 holders.
  • The largest Haemonetics buyer in Q1 2022 was Capital Research Global Investors, an estimated $185M added.
  • The largest Haemonetics seller in Q1 2022 was Armistice Capital, an estimated $46.3M sold.

Based on aggregated 13F filings for Q1 2022.